Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
antiseptic, antitrust, Bailey, Bees®natural, Box, Caribbean, Check, consulting, denominated, dietary, digestive, dressing, DualDefense, Enlight, entail, expire, extend, extended, fair, Febreze, Greek, head, Healthcare®and, homecare, Infinity, internationaland, Kirsten, Las, leveraging, life, Linda, MacKay, Manjit, Marriner, nasal, Omnicare, onthe, percent, pitcher, Point, productsgenerally, Rendle, Renew, shareholder, Sheet, Singh, slower, straight, talent, threatened, top, TripAdvisor, vertical, voluntarily, weakening, William, yogurt
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 Amendment No. 1 to the Clorox Company
- 10.13 Amendment No. 2 to the Clorox Company
- 10.22 Amendment No. 1 to the Clorox Company Executive Retirement Plan
- 10.24 Amendment No. 1 to the Clorox Company 2011
- 10.26 Amended and Restated Joint Venture Agreement Dated As of January 31, 2003
- 21 Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the Chief Executive Officer of the Clorox Company
- 31.2 Certification of the Chief Financial Officer of the Clorox Company
- 32 Certification of the Chief Executive Officer and Chief Financial Officer
- 99.1 Management's Discussion and Analysis of Financial Condition
- 99.2 Valuation and Qualifying Accounts and Reserves
- 99.3 Reconciliation of Economic Profit (Unaudited)
- Download Excel data file
- View Excel data file
Related press release
CLX similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-200722) and in the related Prospectuses of The Clorox Company, and |
(2) | Registration Statements (Form S-8 Nos. 33-41131, including post effective amendments No. 1 and No. 2, 33-56565, 33-56563, 333-29375, 333-16969, 333-44675, 333-86783, 333-131487, 333-69455, including post effective amendment No. 1, 333-90386, including the post effective amendment No. 1, and 333-193913) of The Clorox Company; |
of our reports dated August 16, 2016, with respect to the consolidated financial statements and schedule of The Clorox Company and the effectiveness of internal control over financial reporting of The Clorox Company included in this Annual Report (Form 10-K) of the Clorox Company for the year ended June 30, 2016.
/s/ Ernst & Young LLP
San Francisco, CA
August 16, 2016